1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: JANUARY 31, 2001
COLORADO MEDTECH, INC.
----------------------
(Exact name of registrant as specified in its charter)
COLORADO 000-12471 84-0731006
-------- --------- ----------
(State or other jurisdiction (Commission File (I.R.S. Employer
of incorporation) Number) Identification No.)
6175 LONGBOW DRIVE
BOULDER, COLORADO 80301
-----------------------
(Address, including zip code, of principal executive offices)
(303) 530-2660
--------------
(Registrant's telephone number,
including area code)
2
ITEM 5. OTHER EVENTS.
Colorado MEDtech, Inc. issued a press release regarding a letter from
the FDA. The text of the press release is attached hereto as Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENT AND EXHIBITS.
(c) Exhibits.
No. Description
99.1 Press release dated January 31, 2001
-2-
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DATED, this 31st day of January, 2001.
COLORADO MEDTECH, INC.
By: /s/ PETER J. JENSEN
-------------------------------------
Peter J. Jensen
Vice President
4
EXHIBIT INDEX
EXHIBIT
NO. DESCRIPTION
- ------- -----------
99.1 Press release dated January 31, 2001